SVP, General Counsel, Corp Sec · Emergent BioSolutions Inc. · Common Stock
Side
A
Value
—
Shares
104.3K
Price
—
Executed
Apr 29, 2026
Disclosed
May 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 29 executedMay 1, 2026 disclosed
EBS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 170.9% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Perl Jessica filed this Form 4 reporting a grant or award of EBS on Apr 29, 2026. It became public on May 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, General Counsel, Corp Sec
Perl Jessicacik:0002043716
Issuer
Emergent BioSolutions Inc.cik:0001367644
Revision history · 0
No field has changed since this record was first ingested.
